Deadline: 13-Apr-23
The European Commission (EC) has announced the proposals for the Development and Harmonisation of Methodologies for Assessing Digital Health Technologies in Europe.
Scope
- Digital health technologies have been driving a revolution in health and care ranging from general use of computers to algorithms designed to assist radiologists and radiotherapists in detecting and treating diseases, from robotic surgery to artificial intelligence, machine learning, computer aided decision models, and from mobile apps helping patients to self-manage their disease to electronic health records.
- Digital health technologies are expected to further contribute to better people-centred health and care systems and have the vast potential to improve our ability to accurately prevent, diagnose and treat diseases.
Funding Information
The check will normally be done for the coordinator if the requested grant amount is equal to or greater than EUR 500 000, except for:
- public bodies (entities established as a public body under national law, including local, regional or national authorities) or international organisations; and
- cases where the individual requested grant amount is not more than EUR 60 000 (lowvalue grant).
Expected Outcomes
This topic aims at addressing digital transition challenges through supporting activities that are enabling or contributing to one or several expected impacts of destination 6 “Maintaining an innovative, sustainable and globally competitive health industry”. More specifically, this topic aims at supporting activities that are contributing to the following impact area: “High quality digital services for all”. To that end, proposals under this topic should aim to deliver results that are directed towards and contributing to all of the following expected outcomes:
- Policymakers in the EU have at their disposal a methodological framework and standardised approaches for assessing digital health technologies, that helps them make evidence-based decisions regarding the introduction of digital health technologies in their health and care systems with added value for patients and society.
- Regulators have access to robust, scientifically underpinned evaluation methodologies.
- EU citizens gain faster access to safe and well-performing person-centred digital technologies and are empowered through these tools.
- Health technology developers are better informed and dispose of more guidance on the evidence needed to demonstrate the added value of digital health technologies and have better insights on market predictability.
- (Digital) Health Industry/digital health technology developers and HTA bodies can contribute to the development of EU harmonised Health Technology Assessment (HTA) rules based on common principles.
- Improved cross-border use and interoperability of digital health tools and services throughout the EU and Associated Countries.
- Increased trust in digital health technologies and better integration of digital health tools and services in health and care systems.
Eligibility Criteria
- To become a beneficiary, legal entities must be eligible for funding.
- To be eligible for funding, applicants must be established in one of the following countries:
- the Member States of the European Union, including their outermost regions,
- the Overseas Countries and Territories (OCTs) linked to the Member States,
- countries associated to Horizon Europe;
- the following low- and middle-income countries.
For more information, visit European Commission.
